NCT07536841 Validation of the Odesa Criteria 2026 for Autoimmune Pancreatitis
| NCT ID | NCT07536841 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Military Medical Clinical Center of the Southern Region, Ukraine |
| Condition | Autoimmune Pancreatitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 82 participants |
| Start Date | 2026-05-01 |
| Primary Completion | 2026-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 82 participants in total. It began in 2026-05-01 with a primary completion date of 2026-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This ambispective observational study aims to validate the Odesa Criteria 2026 (OC26), a flexible domain-based point scoring system for diagnosing autoimmune pancreatitis. The study evaluates diagnostic accuracy and reproducibility of OC26 across clinical, serological, morphological, and histological domains.
Eligibility Criteria
Inclusion Criteria: * Adults (≥18 years) undergoing evaluation for suspected autoimmune pancreatitis. * Availability of clinical, serological, imaging, and/or histological data required for OC26 scoring. * Ability to provide informed consent (for prospective participants). Exclusion Criteria: * Confirmed alternative diagnosis explaining pancreatic findings (e.g., pancreatic cancer, acute pancreatitis of other etiology). * Incomplete diagnostic data preventing OC26 scoring. * Prior pancreatic surgery altering diagnostic interpretation.
Contact & Investigator
Oleg Dovbenko
PRINCIPAL INVESTIGATOR
Odesa Regional Clinical Medical Center
Frequently Asked Questions
Who can join the NCT07536841 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Autoimmune Pancreatitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07536841 currently recruiting?
Yes, NCT07536841 is actively recruiting participants. Contact the research team at dovbenko2015@hotmail.com for enrollment information.
Where is the NCT07536841 trial being conducted?
This trial is being conducted at Odesa, Ukraine, Odesa, Ukraine.
Who is sponsoring the NCT07536841 clinical trial?
NCT07536841 is sponsored by Military Medical Clinical Center of the Southern Region, Ukraine. The principal investigator is Oleg Dovbenko at Odesa Regional Clinical Medical Center. The trial plans to enroll 82 participants.